(Q39999255)

16 September 2017

Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study (English)

1 reference

multicenter clinical trial

16 September 2017

0 references

0 references

0 references

0 references

1 reference

1 reference

1

1 reference

16 September 2017

7

Riccardo Autorino

1 reference

16 September 2017

Simone Albisinni

2

1 reference

16 September 2017

Stephen J Freedland

3

1 reference

16 September 2017

Lucio Miano

4

1 reference

16 September 2017

Luca Cindolo

5

1 reference

16 September 2017

Enrico Finazzi Agrò

6

1 reference

16 September 2017

Marco De Sio

8

1 reference

16 September 2017

Luigi Schips

9

1 reference

16 September 2017

Andrea Tubaro

10

1 reference

16 September 2017

16 September 2011

1 reference

16 September 2017

1 reference

16 September 2017

31

1 reference

16 September 2017

7

1 reference

16 September 2017

997-1002

1 reference

Obesity prevalence from a European perspective: a systematic review

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Obesity is a significant risk factor for prostate cancer at the time of biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Effect of Body Mass Index on Histopathologic Parameters: Results of Large European Contemporary Consecutive Open Radical Prostatectomy Series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Metabolic syndrome: definitions and controversies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Effect of dutasteride on the risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

The influence of finasteride on the development of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Obesity and prostate cancer: epidemiology and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

The association between body size, prostate volume and prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Body mass index as a predictor of prostate cancer: development versus detection on biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

The association of body mass index and prostate-specific antigen in a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Molecular interactions of leptin and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

Prostate cancer and adiponectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.08.007

10.1016/J.UROLONC.2011.08.007

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference